Prosecution Insights
Last updated: April 19, 2026
Application No. 18/284,484

ESTIMATING PROPERTIES OF PHYSICAL OBJECTS, BY PROCESSING IMAGE DATA WITH NEURAL NETWORKS

Final Rejection §112
Filed
Sep 27, 2023
Examiner
HARANDI, SIAMAK
Art Unit
2662
Tech Center
2600 — Communications
Assignee
BASF Corporation
OA Round
2 (Final)
91%
Grant Probability
Favorable
3-4
OA Rounds
2y 3m
To Grant
98%
With Interview

Examiner Intelligence

Grants 91% — above average
91%
Career Allow Rate
669 granted / 738 resolved
+28.7% vs TC avg
Moderate +8% lift
Without
With
+7.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 3m
Avg Prosecution
18 currently pending
Career history
756
Total Applications
across all art units

Statute-Specific Performance

§101
16.6%
-23.4% vs TC avg
§103
37.4%
-2.6% vs TC avg
§102
17.6%
-22.4% vs TC avg
§112
14.2%
-25.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 738 resolved cases

Office Action

§112
Response to Amendment Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicant’s response to the last Office Action dated 12/17/2025, as well as amendment to claims, filed on 03/17/2026 have been entered and made of record. In light of Applicant’s amendment of Claim 18, the rejections of record of this claim under 35 U.S.C. 112(a) and 35 U.S.C. 112(b) have been withdrawn. In light of Applicant’s amendment of Claim 19, the rejection of record with respect to this claim has been withdrawn. Status of Claims Claims 1-4, 6-7, and 17-19 are pending. Claim 5 is canceled. Claims 8-16 and 20 are withdrawn from consideration. Response to Arguments Examiner has reviewed Applicant’s arguments with respect to the amended claims filed with the Office on March 17, 2026. Applicant argument presented in Page 7 of its Reply with respect to the rejections of record under 35 U.S.C. 103 have been fully considered, and in light of the amendment of independent claims to incorporate the allowable subject matter of Claim 5, are found persuasive. Therefore, the outstanding rejection of pending claims under 35 U.S.C. 103 has been withdrawn. Accordingly, Claims 1-4, 6-7, and 17-18 are allowed. As shown below, Claim 19 is rejected under 35 U.S.C. 112(b). THIS ACTION IS MADE FINAL. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 19 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 19 recites the limitation "when the program is executed by a processing unit" in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Conclusion and Contact Information THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Siamak HARANDI whose telephone number is (571)270-1832. The examiner can normally be reached Monday - Friday 9:30 - 6:00 ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Amandeep Saini can be reached on (571)272-3382. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Siamak Harandi/Primary Examiner, Art Unit 2662
Read full office action

Prosecution Timeline

Sep 27, 2023
Application Filed
Dec 11, 2025
Non-Final Rejection — §112
Mar 17, 2026
Response Filed
Mar 31, 2026
Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599350
COMPUTED TOMOGRAPHY BASED IMAGING OF VASA VASORUM DENSITY FOR DETECTION AND MONITORING OF INFLAMMATION AND ANGIOGENESIS IN VASCULAR WALL
2y 5m to grant Granted Apr 14, 2026
Patent 12593012
MEDICAL IMAGE PROCESSING DEVICE, MEDICAL IMAGE PROCESSING METHOD, AND ENDOSCOPE SYSTEM
2y 5m to grant Granted Mar 31, 2026
Patent 12582330
SYSTEMS AND METHODS FOR COMPUTER-ASSISTED SHAPE MEASUREMENTS IN VIDEO
2y 5m to grant Granted Mar 24, 2026
Patent 12586228
DEVICE AND METHOD FOR CALCULATING ATRIAL WALL THICKNESS
2y 5m to grant Granted Mar 24, 2026
Patent 12571747
OVERLAY MEASURING METHOD
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
91%
Grant Probability
98%
With Interview (+7.5%)
2y 3m
Median Time to Grant
Moderate
PTA Risk
Based on 738 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month